Logo-apb
Adv Pharm Bull. 2023;13(4): 799-805. doi: 10.34172/apb.2023.074
PMID: 38022811        PMCID: PMC10676543

Research Article

CRISPR/Cas9 Ablated BCL11A Unveils the Genes with Possible Role of Globin Switching

Fatemeh Movahedi Motlagh 1 ORCID, Hamid Reza Soleimanpour‐Lichaei 2, Mehdi Shamsara 3, Azadeh Etemadzadeh 1, Mohammad Hossein Modarressi 1 * ORCID

Cited by CrossRef: 1


1- Zhang S, Dong Z, Yan W, Wang W, Pei Y, Feng Z. The Progress in Treatment of β-Thalassemia and Research on Animal Models of the Disease. Applied Sciences. 2025;15(3):1661 [Crossref]
2- Kerwash E, Sajic M, Rantell K, McBlane J, Johnston J, Niewiarowska A, Butler A, Cole S. Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises. CIMB. 2024;46(8):8209 [Crossref]
3- Liu Y, Yang H, Ren M, Yu Q, Xu Q, Fu X. Orphan Nuclear Receptors TR2 and TR4 in Erythropoiesis: From Mechanisms to Therapies. Biomolecules. 2025;15(6):798 [Crossref]
4- Luo H, Yang Y, Cao X, Deng C, Chen H. Unveiling the Genetic Association Between Hemoglobin Concentration and Amyotrophic Lateral Sclerosis. Brain and Behavior. 2026;16(1) [Crossref]